Konger R, Xuei X, Derr-Yellin E, Fang F, Gao H, Liu Y
Cells. 2024; 13(16).
PMID: 39195246
PMC: 11352891.
DOI: 10.3390/cells13161356.
Zupo R, Castellana F, Crupi P, Desantis A, Rondanelli M, Corbo F
Metabolites. 2023; 13(12).
PMID: 38132869
PMC: 10745457.
DOI: 10.3390/metabo13121187.
Riaz F, Wei P, Pan F
Front Immunol. 2023; 14:1292238.
PMID: 37928539
PMC: 10623333.
DOI: 10.3389/fimmu.2023.1292238.
Lee J, Hu Z, Wang Y, Nath D, Liang W, Cui Y
ACS Med Chem Lett. 2023; 14(6):766-776.
PMID: 37312852
PMC: 10258832.
DOI: 10.1021/acsmedchemlett.3c00056.
Sharma S, Sharma D, Dhobi M, Wang D, Tewari D
Mol Cell Biochem. 2023; 479(3):707-732.
PMID: 37171724
DOI: 10.1007/s11010-023-04755-7.
The effects of olive leaf extract on cardiovascular risk factors in the general adult population: a systematic review and meta-analysis of randomized controlled trials.
Razmpoosh E, Abdollahi S, Mousavirad M, Clark C, Soltani S
Diabetol Metab Syndr. 2022; 14(1):151.
PMID: 36271405
PMC: 9585795.
DOI: 10.1186/s13098-022-00920-y.
Impact of Obesity on the Course of Management of Inflammatory Bowel Disease-A Review.
Michalak A, Kasztelan-Szczerbinska B, Cichoz-Lach H
Nutrients. 2022; 14(19).
PMID: 36235636
PMC: 9573343.
DOI: 10.3390/nu14193983.
The Structure Basis of Phytochemicals as Metabolic Signals for Combating Obesity.
Li X, Zheng L, Zhang B, Deng Z, Luo T
Front Nutr. 2022; 9:913883.
PMID: 35769384
PMC: 9234462.
DOI: 10.3389/fnut.2022.913883.
Efficacy and safety of N-acetyl-GED-0507-34-LEVO gel in patients with moderate-to severe facial acne vulgaris: a phase IIb randomized double-blind, vehicle-controlled trial.
Picardo M, Cardinali C, La Placa M, Lewartowska-Bialek A, Lora V, Micali G
Br J Dermatol. 2022; 187(4):507-514.
PMID: 35553043
PMC: 9796277.
DOI: 10.1111/bjd.21663.
Discovery by Virtual Screening of an Inhibitor of CDK5-Mediated PPARγ Phosphorylation.
OMahony G, Petersen J, Ek M, Rae R, Johansson C, Jianming L
ACS Med Chem Lett. 2022; 13(4):681-686.
PMID: 35450368
PMC: 9014497.
DOI: 10.1021/acsmedchemlett.1c00715.
Histopathological Diagnosis of Nonalcoholic Steatohepatitis (NASH).
Wang W, Ma Y, He T, Mooney E, Guo C, Wang X
Methods Mol Biol. 2022; 2455:49-62.
PMID: 35212985
DOI: 10.1007/978-1-0716-2128-8_5.
A New Series of Aryloxyacetic Acids Endowed with Multi-Target Activity towards Peroxisome Proliferator-Activated Receptors (PPARs), Fatty Acid Amide Hydrolase (FAAH), and Acetylcholinesterase (AChE).
Leuci R, Brunetti L, Laghezza A, Piemontese L, Carrieri A, Pisani L
Molecules. 2022; 27(3).
PMID: 35164223
PMC: 8839882.
DOI: 10.3390/molecules27030958.
Discovery of Potent Glucokinase and PPARγ Dual-Target Agonists through an Innovative Scheme for Regioselective Modification of Silybin.
Zhang Z, Meng Y, Wang Z, Mei Y, Gao S, Wu Y
ACS Omega. 2022; 7(4):3812-3822.
PMID: 35128289
PMC: 8811767.
DOI: 10.1021/acsomega.1c06778.
PPAR Ligands Induce Antiviral Effects Targeting Perturbed Lipid Metabolism during SARS-CoV-2, HCV, and HCMV Infection.
Fantacuzzi M, Amoroso R, Ammazzalorso A
Biology (Basel). 2022; 11(1).
PMID: 35053112
PMC: 8772958.
DOI: 10.3390/biology11010114.
Advances in PPARs Molecular Dynamics and Glitazones as a Repurposing Therapeutic Strategy through Mitochondrial Redox Dynamics against Neurodegeneration.
Durai P, Beeraka N, Ramachandrappa H, Krishnan P, Gudur P, Raghavendra N
Curr Neuropharmacol. 2021; 20(5):893-915.
PMID: 34751120
PMC: 9881103.
DOI: 10.2174/1570159X19666211109141330.
GED-0507 attenuates lung fibrosis by counteracting myofibroblast transdifferentiation in vivo and in vitro.
Speca S, Dubuquoy C, Rousseaux C, Chavatte P, Desreumaux P, Spagnolo P
PLoS One. 2021; 16(9):e0257281.
PMID: 34529707
PMC: 8445472.
DOI: 10.1371/journal.pone.0257281.
The Epithelial-to-Mesenchymal Transition as a Possible Therapeutic Target in Fibrotic Disorders.
Di Gregorio J, Robuffo I, Spalletta S, Giambuzzi G, De Iuliis V, Toniato E
Front Cell Dev Biol. 2021; 8:607483.
PMID: 33409282
PMC: 7779530.
DOI: 10.3389/fcell.2020.607483.
Small-Molecule Modulation of PPARs for the Treatment of Prevalent Vascular Retinal Diseases.
Dou X, Duerfeldt A
Int J Mol Sci. 2020; 21(23).
PMID: 33291567
PMC: 7730325.
DOI: 10.3390/ijms21239251.
The Role of Peroxisome Proliferator-Activated Receptors (PPARs) in Pan-Cancer.
Huang R, Zhang J, Li M, Yan P, Yin H, Zhai S
PPAR Res. 2020; 2020:6527564.
PMID: 33029111
PMC: 7528029.
DOI: 10.1155/2020/6527564.
Beyond the Canonical Endocannabinoid System. A Screening of PPAR Ligands as FAAH Inhibitors.
Brunetti L, Carrieri A, Piemontese L, Tortorella P, Loiodice F, Laghezza A
Int J Mol Sci. 2020; 21(19).
PMID: 32987725
PMC: 7582602.
DOI: 10.3390/ijms21197026.
